Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2020 Sep 16;19(12):2469–2480. doi: 10.1016/j.cgh.2020.09.023

Table 3.

Obstacles in the treatment of early Crohn’s disease

❑ Difficulty in obtaining adequate number of patients with truly early disease
❑ Overlap between early and late mechanisms
❑ Variability of the clinical, pathological and immunological spectrum of CD
❑ Lack of reliable biomarkers associated with early or late disease